CDK4 and neoplasm: To verify whether GLI1 overexpression upregulates cell cycle regulators and the PI3K/AKT pathway in this model, we examined the expression of GLI1, p-AKT, Cyclin D3, CDK4, and Ki67 in the xenograft tumor tissues using immunohistochemical staining.